Literature DB >> 16174234

Microvessel density in ovarian carcinoma: computer image analysis in patients with shorter and longer survival.

M R Raspollini1, G Amunni, A Villanucci, G Baroni, V Boddi, D Rossi Degl'innocenti, G L Taddei.   

Abstract

We previously reported that tumor microvessel density (MVD) may have prognostic significance in ovarian carcinoma. The aim of this study was to compare the intratumoral microvessels using a computer-aided image analysis system between FIGO stage IIIC, serous, G3, ovarian carcinomas obtained from living patients who had no evident disease 5 years after primary treatment and ovarian carcinomas, matched for stage, histopathology, grade of differentiation, and treatment, obtained from patients who had died of progression of disease no later than 1 year after primary treatment. We observed that MVD is statistically correlated, according to the logistic regression in univariate and multivariate ways, with the survival (P= 0.03 and P= 0.05, respectively) and with the progression of the disease during first-line chemotherapy (P= 0.009 and P= 0.012, respectively). In the past years, the modulation of first-line chemotherapeutic treatment has been a question of discussion, because the oncologist observes extremely unpredictable behaviors with surprisingly long survivals and also short survivals. Pathologists may give clinicians some additional prognostic information useful in the management of ovarian carcinoma patients. The results of this study support the hypothesis that the evaluation of MVD with computer image analysis can help clinicians in the choice of the tailored treatment of the single case.

Entities:  

Mesh:

Year:  2005        PMID: 16174234     DOI: 10.1111/j.1525-1438.2005.00146.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

Authors:  Jacqueline V Chapman; Valérie Gouazé-Andersson; Ramin Karimi; Maria C Messner; Myles C Cabot
Journal:  Exp Cell Res       Date:  2011-03-21       Impact factor: 3.905

2.  RGS5 decreases the proliferation of human ovarian carcinoma‑derived primary endothelial cells through the MAPK/ERK signaling pathway in hypoxia.

Authors:  Dan Wang; Yan Xu; Lu Feng; Pin Yin; Shuang Shuang Song; Feng Wu; Ping Yan; Zhiqing Liang
Journal:  Oncol Rep       Date:  2018-10-22       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.